Reporte zur Charge 013HNA

Symptomtext

slept for three days; sweat; dizziness; severe body ache; headache; chills; extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (slept for three days), HYPERHIDROSIS (sweat), DIZZINESS (dizziness), MYALGIA (severe body ache) and HEADACHE (headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013HNA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in December 2020. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced HYPERSOMNIA (slept for three days), HYPERHIDROSIS (sweat), DIZZINESS (dizziness), MYALGIA (severe body ache), HEADACHE (headache), CHILLS (chills) and FATIGUE (extremely tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, HYPERSOMNIA (slept for three days), HYPERHIDROSIS (sweat), DIZZINESS (dizziness), MYALGIA (severe body ache), HEADACHE (headache), CHILLS (chills) and FATIGUE (extremely tired) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter.